This agrees with the data that show that minocycline suppresses constitutive NF-κB activation in OVCAR-3 and SKOV-3 ovarian carcinoma cells, which is correlated with the attenuation of IKK activation [47]. This evidence concerns the gene NFKB1 and ovarian carcinoma.